The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines

Brigette B.Y. Ma, Vivian W.Y. Lui, Edwin P. Hui, Cecilia P.Y. Lau, Kakiu Ho, Margaret H.L. Ng, S. H. Cheng, Sai Wah Tsao, Anthony T.C. Chan

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines'. Together they form a unique fingerprint.

Medicine & Life Sciences